Century Therapeutics, Inc. (IPSC) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 109.16M | 4.17M | 791K | 771K | 855K | 268K | 148K | 99K | 1.72M | 521K | 2.22M | 1.4M | 1.06M | 0 | 0 | 0 |
| Revenue Growth % | -100% | -100% | -100% | -100% | 12667.72% | 1457.09% | 434.46% | 678.79% | -50.29% | -48.56% | -93.35% | -92.91% | 62.57% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.3M | 22.79M | 0 | 2.17M | 3.38M | 0 | 0 | 0 | 1.89M | 1.04M | 935K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 8319.4% | 15397.3% | - | 126.16% | 649.33% | - | - | - | - | - | - |
| Gross Profit | -3M | 0 | 0 | 0 | 109.16M | 4.17M | 791K | 771K | 855K | -22.03M | -22.64M | 99K | -450K | -2.86M | 2.22M | 1.4M | 1.06M | -1.89M | -1.04M | -935K |
| Gross Margin % | - | - | - | - | 100% | 100% | 100% | 100% | 100% | -8219.4% | -15297.3% | 100% | -26.16% | -549.33% | 100% | 100% | 100% | - | - | - |
| Gross Profit Growth % | -102.75% | -100% | -100% | -100% | 12667.72% | 118.94% | 103.49% | 678.79% | 290% | -669.67% | -1117.99% | -92.91% | -142.53% | -51.83% | 313.03% | 249.3% | 211.6% | - | - | - |
| Operating Expenses | 22.5M | 20.65M | 36.12M | 34.66M | 34.99M | 41.46M | 35.58M | 35.53M | 32.16M | 21.73M | 12.99M | 35.18M | 31.63M | 30.44M | 33.96M | 32.75M | 38.49M | 26.09M | 24.78M | 22.09M |
| OpEx % of Revenue | - | - | - | - | 32.05% | 993.46% | 4498.1% | 4607.78% | 3761.87% | 8109.7% | 8774.32% | 35531.31% | 1839.01% | 5843.38% | 1527.07% | 2345.77% | 3638.37% | - | - | - |
| Selling, General & Admin | 6.58M | 956K | 6.83M | 7.8M | 8.41M | 7.75M | 8.35M | 8.31M | 8.74M | 8.59M | 8.99M | 8.23M | 6.73M | 4.86M | 8.06M | 8.25M | 7.3M | 4.29M | 5.24M | 3.15M |
| SG&A % of Revenue | - | - | - | - | 7.7% | 185.84% | 1055.88% | 1077.3% | 1022.57% | 3204.85% | 6071.62% | 8312.12% | 391.4% | 932.63% | 362.59% | 591.19% | 689.79% | - | - | - |
| Research & Development | 14.1M | 19.7M | 22.53M | 26.86M | 26.58M | 29.38M | 27.23M | 27.22M | 23.42M | 23.3M | 26.79M | 22.73M | 24.9M | 25.59M | 25.9M | 24.49M | 21.2M | 21.8M | 19.55M | 18.93M |
| R&D % of Revenue | - | - | - | - | 24.35% | 703.93% | 3442.22% | 3530.48% | 2739.3% | 8692.54% | 18100% | 22956.57% | 1447.62% | 4910.75% | 1164.48% | 1754.58% | 2003.4% | - | - | - |
| Other Operating Expenses | 1000K | 0 | 1000K | 0 | 0 | 1000K | 0 | 0 | 0 | -1000K | -1000K | 1000K | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 |
| Operating Income | -25.5M | -20.65M | -36.12M | -34.66M | 74.18M | -37.28M | -34.79M | -34.76M | -31.31M | -43.76M | -35.63M | -35.08M | -32.08M | -33.31M | -31.74M | -31.35M | -37.44M | -27.97M | -25.83M | -23.02M |
| Operating Margin % | - | - | - | - | 67.95% | -893.46% | -4398.1% | -4507.78% | -3661.87% | -16329.1% | -24071.62% | -35431.31% | -1865.17% | -6392.71% | -1427.07% | -2245.77% | -3538.37% | - | - | - |
| Operating Income Growth % | -134.38% | 44.61% | -3.84% | 0.26% | 336.92% | 14.8% | 2.35% | 0.92% | 2.41% | -31.39% | -12.25% | -11.88% | 14.3% | -19.06% | -22.89% | -36.18% | -107.26% | -83.33% | - | - |
| EBITDA | -22.5M | -17.1M | -32.99M | -31.46M | 77.4M | -33.97M | -31.49M | -31.29M | -28.08M | -40.21M | -32.28M | -31.84M | -29.91M | -29.92M | -28.96M | -29.68M | -36.28M | -26.09M | -24.78M | -22.09M |
| EBITDA Margin % | - | - | - | - | 70.9% | -813.95% | -3981.16% | -4058.75% | -3284.56% | -15003.73% | -21808.11% | -32164.65% | -1739.01% | -5743.38% | -1302.34% | -2126.29% | -3428.73% | - | - | - |
| EBITDA Growth % | -129.07% | 49.65% | -4.78% | -0.54% | 375.6% | 15.53% | 2.43% | 1.73% | 6.11% | -34.38% | -11.43% | -7.28% | 17.55% | -14.7% | -16.87% | -34.4% | -111.97% | -76.89% | - | - |
| D&A (Non-Cash Add-back) | 3M | 3.55M | 3.13M | 3.2M | 3.22M | 3.32M | 3.3M | 3.46M | 3.23M | 3.55M | 3.35M | 3.23M | 2.17M | 3.38M | 2.77M | 1.67M | 1.16M | 1.89M | 1.04M | 935K |
| EBIT | -25.5M | -20.65M | -29.36M | -34.66M | 74.18M | -34.3M | -31.23M | -31.18M | -31.31M | -30.62M | -31.63M | -32.2M | -29.65M | -31.24M | -30.43M | -30.72M | -37.26M | -27.83M | -25.69M | -22.95M |
| Net Interest Income | 2.02M | 1.31M | 1.6M | 2.01M | 2.42M | 2.88M | 3.31M | 3.58M | 3.24M | 3.51M | 3.49M | 2.92M | 2.22M | -413K | -373K | -330K | -314K | -38K | -322K | -318K |
| Interest Income | 2.02M | 1.31M | 1.6M | 2.01M | 2.42M | 2.88M | 3.31M | 3.58M | 3.24M | 3.51M | 3.49M | 3.06M | 2.62M | - | - | - | - | 0 | - | - |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 136K | 404K | 413K | 373K | 330K | 314K | 38K | 322K | 318K |
| Other Income/Expense | 3.86M | 1.41M | 1.7M | 2.12M | 2.38M | 2.99M | 3.56M | 3.57M | 3.25M | 3.5M | 3.5M | 2.74M | 2.02M | 1.66M | 1.01M | 381K | -61K | -178K | -182K | -252K |
| Pretax Income | -21.64M | -19.24M | -34.42M | -32.54M | 76.56M | -34.3M | -31.23M | -31.18M | -28.06M | -40.27M | -32.13M | -32.34M | -30.06M | -31.65M | -30.72M | -30.97M | -37.5M | -28.15M | -26.01M | -23.27M |
| Pretax Margin % | - | - | - | - | 70.13% | -821.88% | -3948.67% | -4044.75% | -3281.99% | -15025% | -21708.11% | -32667.68% | -1747.44% | -6074.86% | -1381.47% | -2218.48% | -3544.14% | - | - | - |
| Income Tax | 0 | -68K | 0 | 0 | 0 | 1.78M | -8K | 22K | 1K | -869K | 592K | 950K | 1.21M | 32K | 25K | 18K | 16K | 43K | 0 | 0 |
| Effective Tax Rate % | 0% | 0.35% | 0% | 0% | 0% | -5.18% | 0.03% | -0.07% | -0% | 2.16% | -1.84% | -2.94% | -4.02% | -0.1% | -0.08% | -0.06% | -0.04% | -0.15% | 0% | 0% |
| Net Income | -21.64M | -19.17M | -34.42M | -32.54M | 76.56M | -36.07M | -31.23M | -31.21M | -28.06M | -39.4M | -32.72M | -33.29M | -31.26M | -31.68M | -30.75M | -30.99M | -37.51M | -28.19M | -26.01M | -23.27M |
| Net Margin % | - | - | - | - | 70.13% | -864.44% | -3947.66% | -4047.6% | -3282.11% | -14700.75% | -22108.11% | -33627.27% | -1817.67% | -6081% | -1382.6% | -2219.77% | -3545.65% | - | - | - |
| Net Income Growth % | -128.27% | 46.86% | -10.24% | -4.27% | 372.82% | 8.44% | 4.57% | 6.26% | 10.24% | -24.35% | -6.41% | -7.43% | 16.66% | -12.37% | -18.22% | -33.15% | -104.45% | -81.53% | - | - |
| Net Income (Continuing) | -21.64M | -19.17M | -34.42M | -32.54M | 76.56M | -36.07M | -31.23M | -31.21M | -28.06M | -39.4M | -32.72M | -33.29M | -31.26M | -31.68M | -30.75M | -30.99M | -37.51M | -28.19M | -26.01M | -23.27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.25 | -0.22 | -0.40 | -0.38 | 0.89 | -0.46 | -0.37 | -0.38 | -0.45 | -0.66 | -0.55 | -0.56 | -0.53 | -0.54 | -0.53 | -0.54 | -0.66 | -0.52 | -0.48 | -0.43 |
| EPS Growth % | -128.09% | 52.17% | -8.11% | 0% | 297.78% | 30.3% | 32.73% | 32.14% | 15.09% | -22.22% | -3.77% | -3.7% | 19.7% | -3.85% | -10.42% | -25.58% | -100% | -40.54% | - | - |
| EPS (Basic) | -0.25 | -0.22 | -0.40 | -0.38 | 0.89 | -0.46 | -0.37 | -0.38 | -0.45 | -0.66 | -0.55 | -0.56 | -0.53 | -0.54 | -0.53 | -0.54 | -0.66 | -0.52 | -0.48 | -0.43 |
| Diluted Shares Outstanding | 86.56M | 86.56M | 86.46M | 86.24M | 86.1M | 78.65M | 84.7M | 82.09M | 62.3M | 59.88M | 59.45M | 59.25M | 58.61M | 58.33M | 57.97M | 57.69M | 57.05M | 54.47M | 54.47M | 54.4M |
| Basic Shares Outstanding | 86.56M | 86.56M | 86.46M | 86.24M | 86.02M | 78.65M | 84.7M | 82.09M | 62.3M | 59.88M | 59.45M | 59.25M | 58.61M | 58.33M | 57.97M | 57.39M | 57.05M | 54.47M | 54.47M | 54.4M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |